What Experts Really Think About Diet Soda
Growing up, Olivia Dreizen Howell, 39, “lived on” diet soda. So did her family. At a family reunion in 1996, everyone sported T-shirts with their shared surname in Diet Coke-can font. “We drank Diet Coke, Diet ginger ale, and Diet Sprite like water—there was no difference in our household,” she says.
Like many, Howell believed that sugar-free soda was a benign choice. But the latest research casts doubt on that assumption, linking diet drinks to mood disorders, fatty liver development, autoimmune diseases, and cancer, to name a few.
[time-brightcove not-tgx=”true”]
Bef...
Source: TIME: Health - April 9, 2024 Category: Consumer Health News Authors: Perri Ormont Blumberg Tags: Uncategorized Evergreen freelance healthscienceclimate Source Type: news
Hormonal Birth Control Doesn ’ t Deserve Its Bad Reputation
Almost two-thirds of U.S. women of reproductive age use some kind of contraception, according to the latest federal data. And millions of them use methods that contain hormones, including birth control pills, intrauterine devices (IUDs), rings, implants, injections, and patches.
Although the specifics vary from method to method, hormonal birth control generally works by halting ovulation and/or changing conditions in the uterus or cervix to prevent pregnancy. And it works well: efficacy rates approach 100% when these methods are used correctly.
[time-brightcove not-tgx=”true”]
But hormonal birth control ...
Source: TIME: Health - April 3, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Evergreen Explainer healthscienceclimate Source Type: news
Doctors found my cancer during abdominal surgery - just like Kate Middleton: Texas woman, 39, shares her health battle
Becky Black, an art curator in Texas, revealed she had been diagnosed with uterine cancer after surgery to remove growths in her uterus at the age of 39 years - in a similar case to Kate's. (Source: the Mail online | Health)
Source: the Mail online | Health - March 27, 2024 Category: Consumer Health News Source Type: news
Drug Could Extend Survival for Uterine Cancer Patients
FRIDAY, March 22, 2024 -- An already approved cancer drug could be an effective treatment for women with advanced, recurring uterine cancer, a new clinical trial shows.Rucaparib, which belongs to a class of drugs called PARP inhibitors, extended... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 22, 2024 Category: General Medicine Source Type: news
Rucaparib Could Extend Survival for Uterine Cancer Patients
FRIDAY, March 22, 2024 -- An already approved cancer drug could be an effective treatment for women with advanced, recurring uterine cancer, a new clinical trial shows.
Rucaparib, which belongs to a class of drugs called PARP inhibitors, extended... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 22, 2024 Category: General Medicine Source Type: news
Customized Radiation of Uterus May Not Compromise Outcomes Customized Radiation of Uterus May Not Compromise Outcomes
Researchers found that patients with locally advanced cervical cancer who received less than whole uterus irradiation had low local recurrence rates and fewer side effects.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 15, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
The First Over-the-Counter Birth Control Pill Is Here
The first birth control pill that people can buy without a prescription, called Opill, is shipping to stores this week.
Perrigo, the Ireland-based company that makes Opill, said the pills should be available to purchase at retail pharmacies and online by the end of March. The pills are designed to be taken daily at about the same time each day, and they will be sold in one-month packs for $19.99 and three-month packs for $49.99.
[time-brightcove not-tgx=”true”]
A spokesperson for CVS, one pharmacy that will be stocking the pill, said the pills will be in more than 7,500 of its stores nationwide and will ...
Source: TIME: Health - March 4, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
Mayo Clinic Minute: Health disparities in gynecologic cancers
Each year, thousands of women are diagnosed with gynecologic cancers in the U.S. While cervical, ovarian and uterine cancer affects all races, Black women are often diagnosed at later stages and are more likely to die from these diseases. Dr. Kristina Butler, a Mayo Clinic gynecologic oncologist, discusses health disparities and prevention. Watch: The Mayo Clinic Minute https://youtu.be/qnJg1eEtcN0 Journalists: Broadcast-quality video (1:05) is in the downloads at the end of this post. Please courtesy: "Mayo… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 15, 2024 Category: Databases & Libraries Source Type: news
How two L ’Oréal alums built TikTok-famous Glow Recipe into a $300 million skincare brand
Good morning, Broadsheet readers! Vice President Kamala Harris described herself as "ready to serve" in an interview last week, uterine cancer continues to rise in prevalence among American women over 50, and two L'Oréal alums built a $300 million skincare brand. - Got that glow. Sarah Lee and…#broadsheet #kamalaharris #loréal #sarahlee #christinechang #seoul #korean #glowrecipe #tiktok #genz (Source: Reuters: Health)
Source: Reuters: Health - February 13, 2024 Category: Consumer Health News Source Type: news
World Cancer Day 2024
Cancer is a major contributor to global mortality, causing about 1 in every 6 deaths and affecting nearly every household (1). Globally, there were an estimated 20 million new cases of cancer and 9.7 million deaths from cancer in 2022. The cancer burden will increase by about 77% by 2050, further straining health systems, people and communities (2).
In the WHO Eastern Mediterranean Region alone, more than 788 000 people were diagnosed with cancer in 2022. This number is projected to double to reach 1.57 million cases by 2045, because of population growth and, more importantly, the high prevalence of cancer risk factors in...
Source: WHO EMRO News - February 1, 2024 Category: Middle East Health Source Type: news
Menopause Is Finally Going Mainstream
Kathryn Clancy wrote an entire book about menstrual cycles. But even she was surprised by some of the pre-menopausal symptoms she recently began to experience at age 44.
“A lot of things that have to do with my uterus, ovaries, and breasts, I have been massively underprepared for as a Ph.D.-level expert in this field,” says Clancy, a professor at the University of Illinois Urbana-Champaign. “That should tell you how even more underprepared most people are.”
[time-brightcove not-tgx=”true”]
Most people who menstruate will experience symptoms including hot flashes, brain fog, and ch...
Source: TIME: Health - January 23, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Source Type: news
ACS: Cancer mortality declines, but incidence rates rise
Overall cancer mortality continues to decline, but incidence rates are up, according to a January 17 report by the American Cancer Society (ACS).
The report shows that there have been more than four million fewer deaths from cancer in the U.S. since 1991. However, it also showed increased incidence for six of the top 10 cancers as the projected number of new diagnoses is over two million for the first time.
“I think we’re all grappling with what the environmental factor that is changing the cancer incidence and mortality among the young," said ACS chief scientific officer William Dahut, MD, at a press conference.
AC...
Source: AuntMinnie.com Headlines - January 17, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties CT Breast Imaging Source Type: news
EU gives green light to new drug to treat endometrial cancer
The new drug treatment for uterine cancer, which is already in use in France on an early access scheme, will be used in combination with chemotherapy. British pharmaceutical company GlaxoSmithKline (GSK) announced on Monday that it has received European approval to market its treatment for…#gsk #europeancommission #jemperli (Source: Reuters: Health)
Source: Reuters: Health - December 26, 2023 Category: Consumer Health News Source Type: news
Endometrial Cancer Therapy Combo Fails 1L Treatment Trial Endometrial Cancer Therapy Combo Fails 1L Treatment Trial
Merck said on Friday a combination therapy being developed with partner Eisai failed a late-stage trial testing it as a first-line treatment for a type of cancer in the uterus lining.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 11, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
What Are Some Risks For Offspring of Assisted Reproductive Technologies?
Discussion
“ART [assisted reproductive technologies] includes all fertility treatments in which either eggs or embryos are handled. The main type of ART is in vitro fertilization (IVF). IVF involves extracting a woman’s eggs, fertilizing the eggs in the laboratory, and then transferring the resulting embryos into the woman’s uterus through the cervix.” In Europe 2-6% of all births are due to some type of ART and ART occurs in 2% of US births. In 2021 in the US, there were 91,906 live births and 97,128 live born infants due to ART. ART is an enabling medical treatment for subfertile or infertile pati...
Source: PediatricEducation.org - December 4, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
